Target intelligence / Profile preview

Peptidoglycan beta-(1,4)-glycosidic bond (PG glycosidic bond)

Target
PG glycosidic bond
Molecular classification
Bacterial cell wall component, Polysaccharide, Glycan
01

Overview

Peptidoglycan, also known as murein, is a unique and essential structural polymer found in the cell walls of almost all bacteria (Vollmer et al., 2008). It consists of glycan chains of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues linked by beta-(1,4)-glycosidic bonds, which are cross-linked by short peptide bridges (Schleifer & Kandler, 1972). This rigid framework provides structural integrity to the bacterial cell, maintaining its shape and protecting it against high internal osmotic pressure (StatPearls, 2023). Because peptidoglycan is absent in eukaryotic cells, it serves as a primary target for the innate immune system and antimicrobial agents (NCBI, 2022). Enzymes such as lysozyme specifically target and hydrolyze the beta-(1,4)-glycosidic bonds between NAM and NAG, leading to cell wall degradation and bacterial lysis (Phillips, 1966). In clinical medicine, while many antibiotics target the synthesis or cross-linking of peptidoglycan, the glycosidic bond itself is a critical site for host defense mechanisms and specialized therapeutic interventions, such as phage-derived endolysins, against bacterial infections (PubChem, 2024).

Other names
Murein glycosidic bondNAM-NAG glycosidic linkageBeta-1,4-glycosidic bond in peptidoglycanPeptidoglycan backbone linkage
02

Mechanism of action

Enzymatic hydrolysis of the beta-(1,4)-glycosidic linkage between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues, leading to the degradation of the glycan backbone and subsequent bacterial cell lysis.

03

Biological functions

Structural integrityOsmotic protectionCell shape maintenanceBacterial cell wall assembly
04

Disease associations

Bacterial infectionSepsisInflammation
05

Safety considerations

Jarisch-Herxheimer reaction due to rapid bacterial lysisRelease of pro-inflammatory Pathogen-Associated Molecular Patterns (PAMPs)Potential for systemic inflammatory response syndrome (SIRS)Bacterial resistance through O-acetylation of peptidoglycan
06

Interacting drugs

Lysozyme

3 more in the full profile.

07

Biomarkers

Peptidoglycan recognition proteins (PGRPs)Muramic acid levelsSoluble peptidoglycan fragmentsNOD1/NOD2 receptor activation

Beyond the preview

Go deeper on Peptidoglycan beta-(1,4)-glycosidic bond (PG glycosidic bond).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidoglycan beta-(1,4)-glycosidic bond (PG glycosidic bond).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call